Admilparant
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Admilparant, covering 2026-01-14 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis [Phase 3]